Clinical Management of Gastro-oesophageal reflux disease (GORD/GERD) and Non-erosive reflux disease (NERD).
Approximately 11.6 % of the Australian population suffer diagnosed reflux conditions. This does not include the undiagnosed in our communities. Gastro-oesophageal diseases are on the rise driven by poor food choices, stress and certain medications.
Use of both prescription and OTC medications to manage the symptoms of GORD, reflux and heartburn are at epidemic proportions with more than 15 million annual prescriptions of the proton-pump inhibitors (PPI’s) esomeprazole and pantoprazole, plus additional OTC PPI use.
Resulting from both the diseases themselves and their conventional treatments, are a myriad of potential nutritional deficiencies and the possibility of more serious health risks. Recovering patient health by addressing the underlying broad mechanisms of the disease is not only essential, but alleviates the pain suffered and attenuates health risks.
Do you know how to effectively prescribe key CAM therapies to address the underlying drivers of your patient’s complex upper GIT diseases and minimise their risk of further complications? Are you confident in the concomitant prescription of CAM, dietary and lifestyle interventions alongside orthodox management to provide symptomatic relief and enhance patient outcomes?
Our speaker, Teresa Mitchell-Paterson will share vital insights of successful clinical therapy and patient cases to advance your clinical expertise in the management of upper GIT dysfunction. Dietary intervention and co-administration of CAM alongside medications will be discussed to optimise outcomes for your patient’s digestive health and overall wellbeing.
Materials available include:
- Video Recordings
- Audio Recordings
- Digital Notes and Resources
- CPE Certificate of Attendance (3 Contact Hours)